Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India
Assessing the Population Level Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India
International Agency for Research on Cancer
5,500 participants
Oct 1, 2020
OBSERVATIONAL
Conditions
Summary
This project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of the HPV vaccine.
Eligibility
Inclusion Criteria1
- Women aged 18 to 22 years, resident of Sikkim and married.
Exclusion Criteria5
- Sample collection should be avoided during active menstruation.
- Women who do not provide written consent
- Women who are not able to cooperate in collection of cervical cell sample or respond to questions due to any acute or severe mental and physical illnesses.
- Women who had undergone hysterectomy.
- Vaccinated in research project
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Women will be approached one time only, when they will attend the gynecology out-patients department for various reasons. After signing the informed consent, the participants will fill in a risk factor questionnaire to study the socio-demographic information, sexual history and HPV vaccination history and the determinent of HPV infection. The questionnaire will be administered by a trained social worker or nurse. A gynecologist will collect cervical cells from the participant's cervix during a gynecological examination. The cervical specimen will be examined for presence of specific HPV genotypes and Chlamydia infection.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04588402